Accéder au contenu
Merck

Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.

PloS one (2012-06-05)
Kyunghee Byun, Enkhjaigal Bayarsaikhan, Daesik Kim, Chae Young Kim, Inhee Mook-Jung, Sun Ha Paek, Seung U Kim, Tadashi Yamamoto, Moo-Ho Won, Byoung-Joon Song, Young Mok Park, Bonghee Lee
RÉSUMÉ

Advanced glycation end products (AGEs) have long been considered as potent molecules promoting neuronal cell death and contributing to neurodegenerative disorders such as Alzheimer's disease (AD). In this study, we demonstrate that AGE-albumin, the most abundant AGE product in human AD brains, is synthesized in activated microglial cells and secreted into the extracellular space. The rate of AGE-albumin synthesis in human microglial cells is markedly increased by amyloid-β exposure and oxidative stress. Exogenous AGE-albumin upregulates the receptor protein for AGE (RAGE) and augments calcium influx, leading to apoptosis of human primary neurons. In animal experiments, soluble RAGE (sRAGE), pyridoxamine or ALT-711 prevented Aβ-induced neuronal death in rat brains. Collectively, these results provide evidence for a new mechanism by which microglial cells promote death of neuronal cells through synthesis and secretion of AGE-albumin, thereby likely contributing to neurodegenerative diseases such as AD.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Amyloid β Protein Fragment 1-42